HDAC9 and prostate carcinoma: In line with site-specific reduction of histone acetylation marks, HDAC levels are elevated in prostate cancer, especially in high-grade tumors, and the levels of HDAC1 and HDAC2 are positively correlated with Gleason score [65,66].